| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingosine | 105 | 2024 | 308 | 18.920 |
Why?
|
| Lysophospholipids | 98 | 2024 | 338 | 18.310 |
Why?
|
| Receptors, Lysosphingolipid | 63 | 2024 | 123 | 12.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 41 | 2007 | 318 | 3.960 |
Why?
|
| Endothelium, Vascular | 46 | 2023 | 4428 | 3.220 |
Why?
|
| Receptors, G-Protein-Coupled | 36 | 2023 | 1248 | 3.140 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 20 | 2020 | 434 | 2.670 |
Why?
|
| Sphingolipids | 13 | 2024 | 178 | 2.610 |
Why?
|
| Endothelial Cells | 32 | 2024 | 3592 | 2.480 |
Why?
|
| Receptors, Lysophospholipid | 32 | 2020 | 40 | 2.340 |
Why?
|
| Propylene Glycols | 16 | 2015 | 91 | 2.170 |
Why?
|
| Isoenzymes | 28 | 2008 | 1687 | 2.080 |
Why?
|
| Neovascularization, Physiologic | 15 | 2020 | 1371 | 1.960 |
Why?
|
| Signal Transduction | 79 | 2024 | 23653 | 1.880 |
Why?
|
| Immediate-Early Proteins | 19 | 2008 | 444 | 1.740 |
Why?
|
| Cyclooxygenase 2 | 32 | 2010 | 597 | 1.690 |
Why?
|
| Neovascularization, Pathologic | 18 | 2020 | 2634 | 1.680 |
Why?
|
| Receptors, Cell Surface | 28 | 2003 | 2820 | 1.600 |
Why?
|
| Capillary Permeability | 11 | 2024 | 773 | 1.480 |
Why?
|
| Apolipoproteins | 5 | 2024 | 328 | 1.480 |
Why?
|
| Lipoproteins, HDL | 6 | 2024 | 682 | 1.200 |
Why?
|
| Animals | 182 | 2024 | 169335 | 1.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 16 | 2022 | 3518 | 1.130 |
Why?
|
| Mice | 113 | 2024 | 82072 | 1.070 |
Why?
|
| Cardiovascular System | 9 | 2020 | 841 | 1.050 |
Why?
|
| Lipocalins | 3 | 2024 | 161 | 0.990 |
Why?
|
| Inflammation | 22 | 2024 | 10868 | 0.950 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2013 | 506 | 0.950 |
Why?
|
| Gene Expression Regulation, Enzymologic | 13 | 2010 | 1169 | 0.920 |
Why?
|
| Adherens Junctions | 6 | 2022 | 90 | 0.910 |
Why?
|
| Homeostasis | 9 | 2024 | 3347 | 0.900 |
Why?
|
| Blood Vessels | 9 | 2016 | 1110 | 0.860 |
Why?
|
| I-kappa B Proteins | 6 | 2001 | 210 | 0.830 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 42 | 0.820 |
Why?
|
| Receptors, Lysophosphatidic Acid | 6 | 2020 | 78 | 0.810 |
Why?
|
| Ceramides | 3 | 2022 | 203 | 0.750 |
Why?
|
| Cell Movement | 25 | 2019 | 5216 | 0.730 |
Why?
|
| Mice, Knockout | 34 | 2024 | 14484 | 0.730 |
Why?
|
| GTP-Binding Proteins | 13 | 2009 | 947 | 0.700 |
Why?
|
| Immunosuppressive Agents | 12 | 2017 | 4207 | 0.680 |
Why?
|
| Endothelium, Lymphatic | 1 | 2020 | 63 | 0.680 |
Why?
|
| Retinal Neovascularization | 1 | 2023 | 288 | 0.680 |
Why?
|
| Cells, Cultured | 50 | 2022 | 19023 | 0.670 |
Why?
|
| Mammary Glands, Animal | 5 | 2013 | 273 | 0.660 |
Why?
|
| Macrophages | 10 | 2019 | 5801 | 0.660 |
Why?
|
| Apolipoproteins A | 1 | 2019 | 96 | 0.650 |
Why?
|
| Chemotaxis | 6 | 2009 | 600 | 0.640 |
Why?
|
| Cadherins | 6 | 2024 | 906 | 0.630 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 118 | 0.630 |
Why?
|
| RNA, Messenger | 42 | 2019 | 12806 | 0.630 |
Why?
|
| Conservation of Natural Resources | 1 | 2021 | 209 | 0.620 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 321 | 0.610 |
Why?
|
| PPAR delta | 2 | 2008 | 40 | 0.600 |
Why?
|
| RNA-Binding Proteins | 6 | 2011 | 1891 | 0.600 |
Why?
|
| MicroRNAs | 5 | 2015 | 3811 | 0.600 |
Why?
|
| Receptors, Prostaglandin E | 4 | 2007 | 56 | 0.600 |
Why?
|
| Leukotriene B4 | 2 | 2018 | 281 | 0.590 |
Why?
|
| Interleukin-1 | 9 | 1999 | 1251 | 0.570 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2005 | 361 | 0.560 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2009 | 1493 | 0.550 |
Why?
|
| Central Nervous System | 4 | 2019 | 1346 | 0.540 |
Why?
|
| Blood-Brain Barrier | 3 | 2020 | 1036 | 0.540 |
Why?
|
| Endocytosis | 6 | 2017 | 959 | 0.530 |
Why?
|
| Serum Albumin | 1 | 2019 | 677 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2020 | 3612 | 0.520 |
Why?
|
| Atherosclerosis | 8 | 2024 | 3431 | 0.500 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2014 | 6 | 0.490 |
Why?
|
| Antigens, Surface | 4 | 2009 | 1616 | 0.490 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 11932 | 0.480 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 659 | 0.480 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 244 | 0.480 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 9 | 2002 | 859 | 0.470 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 133 | 0.470 |
Why?
|
| Lymphocytes | 3 | 2015 | 2614 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 26 | 2022 | 22379 | 0.470 |
Why?
|
| Retinal Vessels | 1 | 2020 | 864 | 0.450 |
Why?
|
| Fibroblast Growth Factor 1 | 7 | 2007 | 53 | 0.420 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2012 | 414 | 0.410 |
Why?
|
| Base Sequence | 24 | 2014 | 12430 | 0.410 |
Why?
|
| Arthritis, Experimental | 6 | 2024 | 293 | 0.410 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2010 | 660 | 0.410 |
Why?
|
| Humans | 171 | 2024 | 768970 | 0.400 |
Why?
|
| Pulmonary Edema | 3 | 2011 | 409 | 0.400 |
Why?
|
| Membrane Proteins | 27 | 2024 | 7885 | 0.400 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3250 | 0.400 |
Why?
|
| Prostaglandins | 10 | 2008 | 398 | 0.400 |
Why?
|
| Synovial Membrane | 9 | 2006 | 536 | 0.400 |
Why?
|
| Cell Line | 30 | 2021 | 15604 | 0.400 |
Why?
|
| Aorta | 2 | 2020 | 2046 | 0.400 |
Why?
|
| Molecular Sequence Data | 25 | 2014 | 17629 | 0.390 |
Why?
|
| Aldehyde-Lyases | 3 | 2008 | 12 | 0.390 |
Why?
|
| Lymph Nodes | 4 | 2019 | 3473 | 0.390 |
Why?
|
| Cell Membrane | 7 | 2019 | 3659 | 0.380 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2019 | 394 | 0.380 |
Why?
|
| Autoimmune Diseases | 5 | 2019 | 2258 | 0.380 |
Why?
|
| rho GTP-Binding Proteins | 5 | 2022 | 279 | 0.380 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 3433 | 0.380 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 34 | 0.370 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2019 | 822 | 0.370 |
Why?
|
| Bone Marrow Cells | 2 | 2009 | 2414 | 0.370 |
Why?
|
| Vasculitis | 1 | 2015 | 525 | 0.370 |
Why?
|
| Models, Biological | 13 | 2019 | 9499 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2020 | 2893 | 0.370 |
Why?
|
| Thrombopoiesis | 1 | 2012 | 166 | 0.360 |
Why?
|
| Students | 1 | 2021 | 1744 | 0.360 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 1036 | 0.360 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 579 | 0.350 |
Why?
|
| Fibrosis | 6 | 2021 | 2080 | 0.350 |
Why?
|
| Ligands | 13 | 2020 | 3283 | 0.350 |
Why?
|
| Cell Migration Inhibition | 1 | 2009 | 97 | 0.340 |
Why?
|
| Vertebrates | 2 | 2008 | 227 | 0.340 |
Why?
|
| Dinoprostone | 10 | 2007 | 597 | 0.330 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2021 | 237 | 0.330 |
Why?
|
| Transfection | 15 | 2007 | 5763 | 0.330 |
Why?
|
| Alternative Splicing | 1 | 2014 | 1105 | 0.330 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 2171 | 0.330 |
Why?
|
| Amino Acid Sequence | 19 | 2019 | 13427 | 0.330 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 214 | 0.320 |
Why?
|
| Neoplasms | 8 | 2021 | 22389 | 0.320 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 9565 | 0.320 |
Why?
|
| Biological Transport | 5 | 2017 | 2085 | 0.320 |
Why?
|
| Zebrafish | 8 | 2019 | 3037 | 0.320 |
Why?
|
| Lipoproteins, LDL | 3 | 2019 | 643 | 0.320 |
Why?
|
| HEK293 Cells | 8 | 2019 | 4290 | 0.310 |
Why?
|
| Erythrocytes | 2 | 2016 | 2421 | 0.310 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 231 | 0.300 |
Why?
|
| Intercellular Junctions | 2 | 1999 | 198 | 0.300 |
Why?
|
| Prostaglandin D2 | 5 | 2001 | 108 | 0.300 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 1399 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 11 | 2024 | 3780 | 0.300 |
Why?
|
| Zebrafish Proteins | 3 | 2014 | 1019 | 0.290 |
Why?
|
| Phosphorylation | 14 | 2013 | 8317 | 0.290 |
Why?
|
| Peritonitis | 1 | 2009 | 368 | 0.290 |
Why?
|
| Inflammation Mediators | 4 | 2023 | 1890 | 0.280 |
Why?
|
| DNA Primers | 10 | 2006 | 2827 | 0.280 |
Why?
|
| Cell Proliferation | 12 | 2020 | 10486 | 0.280 |
Why?
|
| Disease Models, Animal | 17 | 2021 | 18354 | 0.280 |
Why?
|
| Down-Regulation | 4 | 2014 | 2942 | 0.280 |
Why?
|
| Blood Coagulation | 2 | 2022 | 1161 | 0.280 |
Why?
|
| rho-Associated Kinases | 5 | 2017 | 285 | 0.270 |
Why?
|
| Tetradecanoylphorbol Acetate | 8 | 2006 | 826 | 0.270 |
Why?
|
| Endocannabinoids | 1 | 2007 | 113 | 0.270 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 525 | 0.260 |
Why?
|
| Umbilical Veins | 10 | 2003 | 425 | 0.260 |
Why?
|
| Kinetics | 14 | 2010 | 6332 | 0.260 |
Why?
|
| Blood Platelets | 2 | 2016 | 2479 | 0.260 |
Why?
|
| Biochemistry | 1 | 2006 | 116 | 0.260 |
Why?
|
| Enzyme Inhibitors | 5 | 2010 | 3726 | 0.260 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 684 | 0.260 |
Why?
|
| Adenomatous Polyps | 1 | 2006 | 109 | 0.250 |
Why?
|
| Thromboplastin | 1 | 2007 | 288 | 0.250 |
Why?
|
| T-Lymphocytes | 4 | 2017 | 10276 | 0.250 |
Why?
|
| Ferric Compounds | 1 | 2007 | 376 | 0.250 |
Why?
|
| Aromatase | 4 | 2013 | 147 | 0.250 |
Why?
|
| Lung | 9 | 2022 | 10099 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1351 | 0.250 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 703 | 0.250 |
Why?
|
| Transcription, Genetic | 13 | 2007 | 7609 | 0.250 |
Why?
|
| Extracellular Fluid | 2 | 2019 | 165 | 0.250 |
Why?
|
| Neuroblastoma | 4 | 2015 | 1266 | 0.240 |
Why?
|
| Green Fluorescent Proteins | 5 | 2020 | 2067 | 0.240 |
Why?
|
| Protein Binding | 11 | 2019 | 9344 | 0.240 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2004 | 24 | 0.240 |
Why?
|
| Gene Deletion | 5 | 2022 | 2674 | 0.240 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2008 | 1120 | 0.240 |
Why?
|
| Enzyme Activation | 10 | 2017 | 3588 | 0.240 |
Why?
|
| Apoptosis | 11 | 2015 | 9527 | 0.240 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3443 | 0.240 |
Why?
|
| Cloning, Molecular | 9 | 2012 | 4168 | 0.230 |
Why?
|
| Aortic Diseases | 1 | 2010 | 741 | 0.230 |
Why?
|
| Extremities | 2 | 2014 | 870 | 0.230 |
Why?
|
| Catenins | 1 | 2024 | 44 | 0.230 |
Why?
|
| Animal Structures | 1 | 2004 | 26 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2014 | 3744 | 0.220 |
Why?
|
| Hypertension | 3 | 2021 | 8617 | 0.220 |
Why?
|
| Morphogenesis | 4 | 2020 | 747 | 0.220 |
Why?
|
| Lipids | 4 | 2010 | 3345 | 0.220 |
Why?
|
| DNA-Binding Proteins | 7 | 2014 | 9618 | 0.220 |
Why?
|
| Xenopus | 4 | 2001 | 711 | 0.220 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2003 | 617 | 0.220 |
Why?
|
| Regeneration | 2 | 2024 | 1524 | 0.210 |
Why?
|
| 3' Untranslated Regions | 3 | 2014 | 515 | 0.210 |
Why?
|
| Anion Transport Proteins | 2 | 2021 | 141 | 0.210 |
Why?
|
| Cyclooxygenase 1 | 8 | 2004 | 98 | 0.210 |
Why?
|
| Genes, Immediate-Early | 3 | 1998 | 102 | 0.210 |
Why?
|
| Second Messenger Systems | 2 | 2004 | 203 | 0.210 |
Why?
|
| Cell Differentiation | 10 | 2014 | 11684 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 458 | 0.210 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2009 | 163 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2007 | 843 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2017 | 706 | 0.200 |
Why?
|
| Intestinal Mucosa | 4 | 2018 | 3044 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3447 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2014 | 8664 | 0.200 |
Why?
|
| Foam Cells | 2 | 2019 | 68 | 0.200 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2021 | 246 | 0.200 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2019 | 241 | 0.200 |
Why?
|
| Karyopherins | 1 | 2002 | 134 | 0.200 |
Why?
|
| Cell Adhesion | 4 | 2014 | 3102 | 0.200 |
Why?
|
| Computer Communication Networks | 1 | 2004 | 295 | 0.190 |
Why?
|
| Receptors, Growth Factor | 2 | 2001 | 326 | 0.190 |
Why?
|
| Cell Survival | 8 | 2017 | 5793 | 0.190 |
Why?
|
| Fibroblasts | 8 | 2024 | 4179 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2011 | 1246 | 0.190 |
Why?
|
| Imidazoles | 2 | 2005 | 1169 | 0.190 |
Why?
|
| Vascular Diseases | 2 | 2009 | 1163 | 0.190 |
Why?
|
| Wilms Tumor | 3 | 2009 | 378 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3608 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 3408 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2019 | 2474 | 0.190 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 15661 | 0.190 |
Why?
|
| Dactinomycin | 7 | 2000 | 305 | 0.190 |
Why?
|
| Myanmar | 1 | 2021 | 43 | 0.190 |
Why?
|
| Publications | 1 | 2004 | 195 | 0.190 |
Why?
|
| Molecular Chaperones | 2 | 2019 | 763 | 0.190 |
Why?
|
| Antigens, CD | 5 | 2024 | 4032 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.190 |
Why?
|
| Transcription Factors | 10 | 2020 | 12174 | 0.190 |
Why?
|
| Retinal Diseases | 1 | 2007 | 710 | 0.190 |
Why?
|
| Eicosanoids | 2 | 2018 | 284 | 0.190 |
Why?
|
| Receptors, Vitronectin | 1 | 2001 | 48 | 0.180 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 5 | 2007 | 319 | 0.180 |
Why?
|
| Cell Division | 10 | 2004 | 4478 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2005 | 1505 | 0.180 |
Why?
|
| NF-kappa B | 4 | 2015 | 2492 | 0.180 |
Why?
|
| Lymphoid Tissue | 2 | 2017 | 446 | 0.180 |
Why?
|
| Thiazolidinediones | 5 | 2002 | 461 | 0.180 |
Why?
|
| Mutant Proteins | 2 | 2014 | 488 | 0.180 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 1926 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2014 | 3982 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2019 | 4148 | 0.180 |
Why?
|
| Chemokine CXCL12 | 2 | 2012 | 457 | 0.180 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2003 | 542 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 1320 | 0.170 |
Why?
|
| Mice, Nude | 7 | 2015 | 3631 | 0.170 |
Why?
|
| Erythropoiesis | 2 | 2014 | 693 | 0.170 |
Why?
|
| Immune System Phenomena | 1 | 2019 | 17 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 125 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2020 | 118 | 0.170 |
Why?
|
| Lipid Metabolism | 3 | 2024 | 1904 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 9 | 2014 | 6131 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 506 | 0.170 |
Why?
|
| Chloride Channels | 1 | 2021 | 221 | 0.170 |
Why?
|
| RNA Interference | 2 | 2008 | 2835 | 0.170 |
Why?
|
| Edema | 1 | 2023 | 766 | 0.170 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 1712 | 0.160 |
Why?
|
| Thiophenes | 4 | 2018 | 570 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 316 | 0.160 |
Why?
|
| Protein Transport | 7 | 2009 | 1956 | 0.160 |
Why?
|
| Pyrazoles | 6 | 2015 | 2029 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13698 | 0.160 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 808 | 0.160 |
Why?
|
| Lymphangiogenesis | 1 | 2020 | 171 | 0.160 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 435 | 0.160 |
Why?
|
| Galactosylceramides | 1 | 2019 | 90 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2006 | 957 | 0.160 |
Why?
|
| Serine | 1 | 2022 | 831 | 0.160 |
Why?
|
| Cell Communication | 2 | 2020 | 1660 | 0.150 |
Why?
|
| Blotting, Western | 11 | 2014 | 5033 | 0.150 |
Why?
|
| Bleomycin | 2 | 2022 | 493 | 0.150 |
Why?
|
| Acetaminophen | 1 | 2022 | 556 | 0.150 |
Why?
|
| Cerebral Arteries | 1 | 2020 | 489 | 0.150 |
Why?
|
| Kidney | 6 | 2020 | 7058 | 0.150 |
Why?
|
| Lymphopenia | 2 | 2011 | 300 | 0.150 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 17173 | 0.150 |
Why?
|
| Lymphatic Vessels | 2 | 2020 | 356 | 0.150 |
Why?
|
| Neurogenesis | 2 | 2015 | 865 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4939 | 0.150 |
Why?
|
| Colon | 2 | 2018 | 1803 | 0.150 |
Why?
|
| Female | 44 | 2024 | 397515 | 0.150 |
Why?
|
| Blotting, Northern | 8 | 2003 | 1553 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 1998 | 238 | 0.150 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 3 | 2007 | 48 | 0.140 |
Why?
|
| Luminescence | 1 | 2017 | 108 | 0.140 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 1231 | 0.140 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 487 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2010 | 2709 | 0.140 |
Why?
|
| Rats | 16 | 2007 | 23786 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 3775 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 1 | 2018 | 513 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 379 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2011 | 2460 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 2059 | 0.140 |
Why?
|
| Nephritis, Interstitial | 1 | 2018 | 158 | 0.140 |
Why?
|
| Actins | 3 | 2018 | 2065 | 0.130 |
Why?
|
| Stem Cells | 1 | 2009 | 3539 | 0.130 |
Why?
|
| DNA | 6 | 2001 | 7214 | 0.130 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 674 | 0.130 |
Why?
|
| Transduction, Genetic | 3 | 2008 | 902 | 0.130 |
Why?
|
| Ureteral Obstruction | 2 | 2018 | 297 | 0.130 |
Why?
|
| Tight Junctions | 2 | 2017 | 324 | 0.130 |
Why?
|
| G1 Phase | 3 | 2006 | 403 | 0.130 |
Why?
|
| Heart | 4 | 2015 | 4447 | 0.130 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2015 | 56 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 587 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 4528 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 16053 | 0.130 |
Why?
|
| Thromboxanes | 2 | 2006 | 45 | 0.130 |
Why?
|
| Prostaglandins E | 1 | 1995 | 166 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 522 | 0.130 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2543 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 4 | 2012 | 89 | 0.130 |
Why?
|
| Chlorambucil | 1 | 2015 | 42 | 0.130 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 1251 | 0.120 |
Why?
|
| Protein Isoforms | 4 | 2018 | 1714 | 0.120 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2015 | 21 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 633 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2021 | 951 | 0.120 |
Why?
|
| Oxidoreductases | 1 | 2017 | 412 | 0.120 |
Why?
|
| Research | 1 | 2004 | 1981 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1682 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 877 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 980 | 0.120 |
Why?
|
| Tristetraprolin | 1 | 2014 | 40 | 0.120 |
Why?
|
| Myelin Sheath | 1 | 2019 | 653 | 0.120 |
Why?
|
| Caspases | 2 | 2013 | 881 | 0.120 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2013 | 105 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2000 | 2937 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 492 | 0.120 |
Why?
|
| Myelin Proteins | 1 | 2015 | 212 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2812 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 4 | 2003 | 148 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6569 | 0.120 |
Why?
|
| Oxadiazoles | 3 | 2018 | 94 | 0.120 |
Why?
|
| Chemokines, C | 1 | 2014 | 10 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 874 | 0.120 |
Why?
|
| Cricetulus | 2 | 2014 | 812 | 0.120 |
Why?
|
| Culture Media, Conditioned | 3 | 2006 | 521 | 0.120 |
Why?
|
| Pyridines | 6 | 2015 | 2895 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 3 | 2012 | 2635 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2019 | 840 | 0.110 |
Why?
|
| Cyclic AMP | 3 | 2009 | 1469 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 224 | 0.110 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2000 | 461 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2015 | 225 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 2015 | 252 | 0.110 |
Why?
|
| Tissue Distribution | 3 | 2012 | 2298 | 0.110 |
Why?
|
| 3T3 Cells | 4 | 1999 | 1085 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 152 | 0.110 |
Why?
|
| Male | 29 | 2024 | 365203 | 0.110 |
Why?
|
| Mutagenesis | 1 | 1998 | 1229 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2017 | 538 | 0.110 |
Why?
|
| Lymphokines | 2 | 2001 | 927 | 0.110 |
Why?
|
| Atrioventricular Node | 1 | 2014 | 180 | 0.110 |
Why?
|
| Cyclin D1 | 2 | 2008 | 453 | 0.110 |
Why?
|
| Sphingomyelins | 1 | 2014 | 105 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2008 | 1095 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1252 | 0.110 |
Why?
|
| Immunohistochemistry | 12 | 2014 | 11116 | 0.110 |
Why?
|
| Cycloheximide | 6 | 1997 | 341 | 0.110 |
Why?
|
| Epoprostenol | 4 | 1989 | 246 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 4413 | 0.110 |
Why?
|
| Laminin | 2 | 2005 | 406 | 0.110 |
Why?
|
| Dexamethasone | 3 | 1999 | 1965 | 0.110 |
Why?
|
| Topotecan | 1 | 2013 | 131 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 1112 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1904 | 0.100 |
Why?
|
| Receptors, LDL | 1 | 2015 | 492 | 0.100 |
Why?
|
| Pseudopodia | 2 | 2020 | 167 | 0.100 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2013 | 70 | 0.100 |
Why?
|
| Embryonic Development | 2 | 2015 | 724 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 4 | 2001 | 154 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2019 | 3232 | 0.100 |
Why?
|
| Immune System | 2 | 2011 | 800 | 0.100 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 306 | 0.100 |
Why?
|
| Exons | 2 | 2014 | 2395 | 0.100 |
Why?
|
| beta-Alanine | 1 | 2013 | 82 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 1997 | 2094 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3813 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 83 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 968 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2017 | 2149 | 0.100 |
Why?
|
| Hemorheology | 1 | 2012 | 144 | 0.100 |
Why?
|
| Phylogeny | 3 | 2005 | 2843 | 0.100 |
Why?
|
| Recombinant Proteins | 7 | 2005 | 6512 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2041 | 0.100 |
Why?
|
| Pertussis Toxin | 3 | 2006 | 176 | 0.100 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 2542 | 0.100 |
Why?
|
| GATA4 Transcription Factor | 1 | 2012 | 125 | 0.100 |
Why?
|
| Fatty Acids | 2 | 2017 | 1812 | 0.100 |
Why?
|
| Interleukin-17 | 2 | 2019 | 925 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 314 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2005 | 594 | 0.100 |
Why?
|
| Germinal Center | 1 | 2014 | 380 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 1133 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 10765 | 0.090 |
Why?
|
| Proteoglycans | 2 | 2005 | 809 | 0.090 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 751 | 0.090 |
Why?
|
| Genome | 2 | 2012 | 1754 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2009 | 2884 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 378 | 0.090 |
Why?
|
| Autoimmunity | 1 | 2019 | 1360 | 0.090 |
Why?
|
| Oocytes | 3 | 2001 | 1172 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2015 | 1461 | 0.090 |
Why?
|
| Oxygen | 1 | 2022 | 4272 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 7 | 1997 | 6086 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 5804 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 1006 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2017 | 8544 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
| Thioglycolates | 1 | 2009 | 37 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2012 | 321 | 0.090 |
Why?
|
| Suramin | 2 | 2000 | 34 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2005 | 2395 | 0.090 |
Why?
|
| Lipoproteins | 2 | 2015 | 880 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2010 | 147 | 0.090 |
Why?
|
| Disease | 2 | 2008 | 673 | 0.090 |
Why?
|
| Time Factors | 11 | 2009 | 40261 | 0.080 |
Why?
|
| RNA Stability | 2 | 2009 | 321 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 1658 | 0.080 |
Why?
|
| Terminology as Topic | 2 | 2010 | 1541 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 422 | 0.080 |
Why?
|
| Protein Conformation | 3 | 2011 | 3956 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 4356 | 0.080 |
Why?
|
| Cortactin | 2 | 2006 | 28 | 0.080 |
Why?
|
| Stress, Mechanical | 2 | 2020 | 1680 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 255 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2016 | 758 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1820 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 251 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 188 | 0.080 |
Why?
|
| Cytokines | 4 | 2018 | 7453 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 379 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2005 | 481 | 0.080 |
Why?
|
| Gene Expression | 7 | 2006 | 7603 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2014 | 1599 | 0.080 |
Why?
|
| Heart Rate | 2 | 2014 | 4217 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| Body Patterning | 1 | 2012 | 634 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2005 | 2089 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 610 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 148 | 0.080 |
Why?
|
| Sulfonamides | 3 | 2007 | 1981 | 0.070 |
Why?
|
| Phospholipase C beta | 1 | 2008 | 49 | 0.070 |
Why?
|
| Endotoxins | 1 | 2010 | 520 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 873 | 0.070 |
Why?
|
| Luciferases | 3 | 2017 | 713 | 0.070 |
Why?
|
| Mice, 129 Strain | 2 | 2020 | 369 | 0.070 |
Why?
|
| Paracrine Communication | 1 | 2009 | 278 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 729 | 0.070 |
Why?
|
| Receptor, erbB-2 | 3 | 2013 | 2606 | 0.070 |
Why?
|
| Cell Nucleus | 6 | 2000 | 2885 | 0.070 |
Why?
|
| Triglycerides | 1 | 2015 | 2464 | 0.070 |
Why?
|
| Kidney Neoplasms | 3 | 2009 | 4300 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1997 | 2848 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 792 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 2018 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1811 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 212 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.070 |
Why?
|
| Diet | 1 | 2005 | 8088 | 0.070 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2007 | 125 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2009 | 362 | 0.070 |
Why?
|
| Stress Fibers | 1 | 2007 | 55 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2009 | 478 | 0.070 |
Why?
|
| Stria Vascularis | 1 | 2007 | 30 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 435 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1994 | 1305 | 0.070 |
Why?
|
| Transplantation Chimera | 1 | 2009 | 594 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 651 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2008 | 3412 | 0.070 |
Why?
|
| Luminescent Proteins | 2 | 1999 | 839 | 0.070 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 628 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 1065 | 0.070 |
Why?
|
| HCT116 Cells | 1 | 2007 | 405 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 1995 | 1183 | 0.070 |
Why?
|
| Salivary Glands | 1 | 2008 | 231 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1010 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 221 | 0.070 |
Why?
|
| Microcirculation | 2 | 2021 | 1281 | 0.070 |
Why?
|
| Collagen | 2 | 2005 | 2646 | 0.070 |
Why?
|
| Calcium | 5 | 2006 | 5792 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 113 | 0.070 |
Why?
|
| Chromans | 3 | 2001 | 116 | 0.070 |
Why?
|
| Chordata | 1 | 2005 | 6 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 2403 | 0.060 |
Why?
|
| Food Coloring Agents | 1 | 2005 | 7 | 0.060 |
Why?
|
| Ciona intestinalis | 1 | 2005 | 10 | 0.060 |
Why?
|
| Bacteriorhodopsins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Sjogren's Syndrome | 1 | 2008 | 241 | 0.060 |
Why?
|
| Skin | 2 | 2018 | 4506 | 0.060 |
Why?
|
| Endothelium | 3 | 2024 | 768 | 0.060 |
Why?
|
| COS Cells | 2 | 2015 | 1135 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1742 | 0.060 |
Why?
|
| Tyrosine | 2 | 2005 | 1427 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2222 | 0.060 |
Why?
|
| Inbreeding | 1 | 2005 | 48 | 0.060 |
Why?
|
| Breast Neoplasms | 5 | 2007 | 21188 | 0.060 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2007 | 255 | 0.060 |
Why?
|
| Genes, Dominant | 3 | 2008 | 856 | 0.060 |
Why?
|
| Intracellular Space | 1 | 2006 | 199 | 0.060 |
Why?
|
| Nervous System | 1 | 2008 | 546 | 0.060 |
Why?
|
| Chemokines | 1 | 2009 | 963 | 0.060 |
Why?
|
| S Phase | 1 | 2006 | 424 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2003 | 2179 | 0.060 |
Why?
|
| Leukotrienes | 2 | 2004 | 232 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2748 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1966 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2009 | 967 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 662 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 1996 | 777 | 0.060 |
Why?
|
| Anthozoa | 1 | 2005 | 65 | 0.060 |
Why?
|
| Germ Cells | 1 | 2009 | 644 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1994 | 1892 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 369 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1564 | 0.060 |
Why?
|
| Adipocytes | 2 | 2011 | 1199 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1026 | 0.060 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2005 | 108 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2006 | 565 | 0.060 |
Why?
|
| Heparin | 1 | 1991 | 1636 | 0.060 |
Why?
|
| Galactosidases | 1 | 2004 | 55 | 0.060 |
Why?
|
| Organic Chemicals | 1 | 2005 | 211 | 0.060 |
Why?
|
| Mitogens | 2 | 2003 | 229 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2014 | 381 | 0.060 |
Why?
|
| Reproduction | 1 | 2008 | 646 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 567 | 0.060 |
Why?
|
| Hematopoiesis | 2 | 2012 | 2059 | 0.060 |
Why?
|
| Genitalia | 1 | 2004 | 114 | 0.060 |
Why?
|
| Plasma | 1 | 2007 | 585 | 0.060 |
Why?
|
| Invertebrates | 1 | 2004 | 55 | 0.060 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2004 | 114 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1750 | 0.060 |
Why?
|
| Drug Antagonism | 1 | 2003 | 50 | 0.060 |
Why?
|
| Platelet Activating Factor | 1 | 2004 | 143 | 0.060 |
Why?
|
| Catalase | 1 | 2004 | 215 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2015 | 1542 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3682 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1536 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2005 | 309 | 0.050 |
Why?
|
| Serotonin | 1 | 2008 | 1043 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 840 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2005 | 997 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 2749 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 742 | 0.050 |
Why?
|
| Paroxetine | 1 | 2024 | 181 | 0.050 |
Why?
|
| Thiazoles | 5 | 2002 | 1542 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2004 | 699 | 0.050 |
Why?
|
| Deafness | 1 | 2007 | 462 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 693 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 267 | 0.050 |
Why?
|
| Plants | 1 | 2004 | 332 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 559 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 197 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 874 | 0.050 |
Why?
|
| Protein Kinase C | 3 | 2009 | 1207 | 0.050 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2015 | 91 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 642 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2004 | 611 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2005 | 1154 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 977 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 2 | 2001 | 419 | 0.050 |
Why?
|
| Symporters | 1 | 2004 | 363 | 0.050 |
Why?
|
| Monocytes | 2 | 2019 | 2603 | 0.050 |
Why?
|
| Synovial Fluid | 2 | 2012 | 393 | 0.050 |
Why?
|
| Photons | 1 | 2005 | 595 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1902 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 478 | 0.050 |
Why?
|
| Fungi | 1 | 2004 | 345 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 203 | 0.050 |
Why?
|
| Phenotype | 3 | 2022 | 16731 | 0.050 |
Why?
|
| Arthritis | 2 | 2000 | 684 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8745 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 1156 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4794 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1973 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2002 | 1890 | 0.040 |
Why?
|
| Arachidonic Acid | 2 | 2001 | 429 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 109 | 0.040 |
Why?
|
| Enzyme Induction | 3 | 2004 | 455 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1992 | 706 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4926 | 0.040 |
Why?
|
| Glycocalyx | 1 | 2021 | 99 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 310 | 0.040 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 179 | 0.040 |
Why?
|
| Aspirin | 3 | 1989 | 3135 | 0.040 |
Why?
|
| Microbodies | 1 | 2000 | 34 | 0.040 |
Why?
|
| Epoxy Compounds | 1 | 2000 | 137 | 0.040 |
Why?
|
| Auranofin | 1 | 1999 | 16 | 0.040 |
Why?
|
| Th17 Cells | 2 | 2019 | 791 | 0.040 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2024 | 614 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1340 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1181 | 0.040 |
Why?
|
| RNA Transport | 1 | 2019 | 43 | 0.040 |
Why?
|
| Aequorin | 1 | 1999 | 15 | 0.040 |
Why?
|
| Prostaglandins A | 1 | 1999 | 13 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2015 | 731 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 2 | 2014 | 910 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 1726 | 0.040 |
Why?
|
| Species Specificity | 1 | 2004 | 2417 | 0.040 |
Why?
|
| Mucins | 1 | 2003 | 571 | 0.040 |
Why?
|
| Epidermal Growth Factor | 3 | 1989 | 697 | 0.040 |
Why?
|
| Light | 1 | 2005 | 1355 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2004 | 5801 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2003 | 644 | 0.040 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2003 | 480 | 0.040 |
Why?
|
| Arthus Reaction | 1 | 2018 | 14 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2004 | 1266 | 0.040 |
Why?
|
| Peroxidases | 1 | 1999 | 135 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 469 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 2960 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 577 | 0.040 |
Why?
|
| Brain | 3 | 2017 | 27453 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2004 | 1970 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 682 | 0.040 |
Why?
|
| beta Catenin | 1 | 2024 | 1047 | 0.040 |
Why?
|
| Indomethacin | 2 | 1992 | 323 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2771 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2004 | 1077 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 2018 | 122 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 886 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 383 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2011 | 122 | 0.040 |
Why?
|
| Thrombosis | 1 | 2012 | 2956 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 751 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 572 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 527 | 0.040 |
Why?
|
| Glycolipids | 1 | 2019 | 205 | 0.040 |
Why?
|
| Indans | 1 | 2018 | 92 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1517 | 0.040 |
Why?
|
| Histones | 1 | 2008 | 2603 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 128 | 0.040 |
Why?
|
| RNA, Untranslated | 1 | 2001 | 457 | 0.040 |
Why?
|
| Bacterial Toxins | 2 | 1995 | 922 | 0.040 |
Why?
|
| Fibrin | 1 | 2001 | 514 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 6401 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1997 | 107 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 1999 | 739 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 1093 | 0.040 |
Why?
|
| RNA | 2 | 2021 | 2727 | 0.040 |
Why?
|
| Joints | 1 | 2019 | 324 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2202 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2001 | 524 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2020 | 917 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2452 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 799 | 0.040 |
Why?
|
| Immunity | 1 | 2003 | 1003 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 2017 | 120 | 0.030 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1996 | 16 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1997 | 226 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 557 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22296 | 0.030 |
Why?
|
| Drug Synergism | 3 | 2013 | 1762 | 0.030 |
Why?
|
| Ribonuclease H | 1 | 1996 | 52 | 0.030 |
Why?
|
| Homozygote | 2 | 2017 | 1780 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 96 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 692 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 1998 | 2276 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2017 | 426 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2019 | 1647 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5716 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 197 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1999 | 1216 | 0.030 |
Why?
|
| Proteomics | 2 | 2007 | 3914 | 0.030 |
Why?
|
| Osteoarthritis | 4 | 2006 | 1070 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2683 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 1997 | 253 | 0.030 |
Why?
|
| Poly A | 1 | 1996 | 180 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7245 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
| Anilides | 1 | 2018 | 414 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 1999 | 966 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 1731 | 0.030 |
Why?
|
| Lung Neoplasms | 4 | 2001 | 13594 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 240 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2007 | 669 | 0.030 |
Why?
|
| Pregnancy | 2 | 2008 | 30265 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3450 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 556 | 0.030 |
Why?
|
| Rats, Inbred Lew | 4 | 2000 | 1163 | 0.030 |
Why?
|
| Spleen | 2 | 2017 | 2294 | 0.030 |
Why?
|
| Autoantigens | 1 | 2019 | 891 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1162 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 999 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2014 | 72 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2004 | 3449 | 0.030 |
Why?
|
| Sirolimus | 1 | 2001 | 1540 | 0.030 |
Why?
|
| Mutation | 5 | 2015 | 30266 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 4592 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1667 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 564 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 958 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 190 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2007 | 87 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 849 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1524 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 838 | 0.030 |
Why?
|
| Neutrophils | 1 | 2006 | 3785 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1498 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 2014 | 5505 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1629 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2019 | 2748 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1994 | 816 | 0.030 |
Why?
|
| Binding Sites | 3 | 2014 | 6023 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2020 | 1245 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 417 | 0.030 |
Why?
|
| Cell Death | 2 | 2013 | 1682 | 0.030 |
Why?
|
| Gastrulation | 1 | 2012 | 37 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 18068 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2001 | 5434 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2431 | 0.020 |
Why?
|
| Cattle | 3 | 2001 | 3819 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 2682 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 1057 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 761 | 0.020 |
Why?
|
| Liver | 1 | 2008 | 7578 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 2 | 1989 | 212 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1495 | 0.020 |
Why?
|
| Cricetinae | 2 | 2006 | 2423 | 0.020 |
Why?
|
| ADP Ribose Transferases | 1 | 1991 | 90 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1894 | 0.020 |
Why?
|
| Exotoxins | 1 | 1991 | 123 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9384 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1990 | 0.020 |
Why?
|
| Myocardium | 1 | 2004 | 4790 | 0.020 |
Why?
|
| Cytotoxins | 1 | 1991 | 154 | 0.020 |
Why?
|
| Ibuprofen | 1 | 1992 | 229 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9264 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2798 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2986 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2734 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2018 | 1410 | 0.020 |
Why?
|
| Forecasting | 1 | 1999 | 2945 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 612 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3525 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2005 | 1505 | 0.020 |
Why?
|
| Autopsy | 1 | 2013 | 1013 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 9213 | 0.020 |
Why?
|
| Epitopes | 1 | 1996 | 2529 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 1996 | 2167 | 0.020 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2009 | 37 | 0.020 |
Why?
|
| Thymidine | 1 | 1989 | 297 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 1993 | 348 | 0.020 |
Why?
|
| Phospholipase D | 1 | 2009 | 70 | 0.020 |
Why?
|
| Middle Aged | 7 | 2014 | 223737 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5906 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 204 | 0.020 |
Why?
|
| Diglycerides | 1 | 2009 | 176 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 586 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 13091 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 190 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2011 | 5404 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 8055 | 0.020 |
Why?
|
| Gestational Age | 1 | 1997 | 3621 | 0.020 |
Why?
|
| Aged | 5 | 2014 | 171786 | 0.020 |
Why?
|
| Virulence Factors | 1 | 1991 | 502 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2007 | 44 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1608 | 0.020 |
Why?
|
| Sheep | 2 | 1990 | 1451 | 0.020 |
Why?
|
| Psoriasis | 1 | 2015 | 926 | 0.020 |
Why?
|
| Globins | 1 | 1988 | 405 | 0.020 |
Why?
|
| Molybdenum | 1 | 2007 | 45 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1062 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 116 | 0.020 |
Why?
|
| Growth Substances | 1 | 1989 | 760 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 440 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2006 | 43 | 0.020 |
Why?
|
| Seminal Vesicles | 1 | 1986 | 103 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 4919 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6805 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 1952 | 0.020 |
Why?
|
| Disease Progression | 1 | 2003 | 13674 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2913 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6901 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 412 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 752 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1988 | 359 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1550 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2007 | 385 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 276 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1989 | 1135 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3702 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 290 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3621 | 0.010 |
Why?
|
| Amyloid | 1 | 1989 | 854 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1399 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2442 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 474 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1988 | 905 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1276 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2001 | 664 | 0.010 |
Why?
|
| CHO Cells | 1 | 2006 | 1379 | 0.010 |
Why?
|
| Phthalazines | 1 | 2006 | 397 | 0.010 |
Why?
|
| Tumor Necrosis Factors | 1 | 2003 | 109 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 550 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2002 | 91 | 0.010 |
Why?
|
| Amides | 1 | 2005 | 452 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9549 | 0.010 |
Why?
|
| Tunica Media | 1 | 2002 | 111 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1985 | 423 | 0.010 |
Why?
|
| Epithelium | 1 | 2007 | 1607 | 0.010 |
Why?
|
| Aromatase Inhibitors | 1 | 2006 | 519 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2008 | 1530 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 229 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 2002 | 218 | 0.010 |
Why?
|
| International Agencies | 1 | 2002 | 244 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 283 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5707 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 521 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2003 | 287 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 12095 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2004 | 1034 | 0.010 |
Why?
|
| Leukotriene Antagonists | 1 | 2001 | 124 | 0.010 |
Why?
|
| Temperature | 1 | 2007 | 2235 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3629 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.010 |
Why?
|
| Rabbits | 1 | 1986 | 4774 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1999 | 34 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2002 | 459 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2000 | 366 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1999 | 113 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 873 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7478 | 0.010 |
Why?
|
| Heart Failure | 1 | 2024 | 11879 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2000 | 340 | 0.010 |
Why?
|
| Spodoptera | 1 | 1999 | 140 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1991 | 1142 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 605 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3163 | 0.010 |
Why?
|
| Biology | 1 | 2001 | 292 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 1342 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 898 | 0.010 |
Why?
|
| United States | 1 | 2006 | 73186 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 746 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 317 | 0.010 |
Why?
|
| Cornea | 1 | 2006 | 1315 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2204 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 911 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1998 | 364 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 1151 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11230 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 1435 | 0.010 |
Why?
|
| Ankle | 1 | 2000 | 353 | 0.010 |
Why?
|
| Prostatic Hyperplasia | 1 | 2000 | 523 | 0.010 |
Why?
|
| Cysteine | 1 | 2001 | 897 | 0.010 |
Why?
|
| Clone Cells | 1 | 2000 | 1670 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12801 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 1855 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 1748 | 0.010 |
Why?
|
| Adult | 4 | 2008 | 223851 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2000 | 944 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 30046 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2000 | 1895 | 0.010 |
Why?
|
| Rats, Nude | 1 | 1992 | 106 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1993 | 458 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 825 | 0.010 |
Why?
|
| Streptococcus | 1 | 1992 | 198 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1991 | 88 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2238 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1991 | 196 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 36556 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4568 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 10115 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1990 | 61 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42683 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1990 | 223 | 0.010 |
Why?
|
| Genomics | 1 | 2005 | 5928 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6232 | 0.000 |
Why?
|
| Cell Wall | 1 | 1992 | 421 | 0.000 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1988 | 71 | 0.000 |
Why?
|
| Templates, Genetic | 1 | 1988 | 188 | 0.000 |
Why?
|
| RNA, Small Nuclear | 1 | 1988 | 71 | 0.000 |
Why?
|
| RNA Precursors | 1 | 1988 | 196 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 59739 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1081 | 0.000 |
Why?
|
| Molecular Structure | 1 | 1990 | 1885 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80960 | 0.000 |
Why?
|
| Genes | 1 | 1988 | 1824 | 0.000 |
Why?
|
| Plasmids | 1 | 1989 | 2269 | 0.000 |
Why?
|
| Autoradiography | 1 | 1985 | 728 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1985 | 296 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1990 | 3057 | 0.000 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1989 | 1116 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2087 | 0.000 |
Why?
|
| DNA Replication | 1 | 1990 | 1428 | 0.000 |
Why?
|
| Knee Joint | 1 | 1992 | 1685 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2003 | 6982 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1988 | 3076 | 0.000 |
Why?
|
| Blood | 1 | 1985 | 599 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 89244 | 0.000 |
Why?
|